Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients;Utilité de la procalcitonine dans le diagnostic et le suivi des infections chez les patients neutropéniques f́briles

Revue Medicale Suisse

Volumn 1, Issue 13, 2005, Pages 878-886

  Robinson, James Owen ^a   Calandra, Thierry ^a   Marchetti, Oscar ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; CALCITONIN; GLYCOPROTEIN; PROTEIN PRECURSOR;

BACTERIAL INFECTION; DRUG TOLERANCE; FEBRILE NEUTROPENIA; FEVER; FOLLOW UP; HUMAN; REVIEW; SEPSIS; BLOOD; DIFFERENTIAL DIAGNOSIS; NEUTROPENIA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; FEVER; GLYCOPROTEINS; HUMANS; NEUTROPENIA; PROTEIN PRECURSORS;

EID: 19444385405     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
2. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-7.
3. Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997;24:1240-2.
4. Viallon A, Zeni F, Lambert C, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 1999;28:1313-6.
5. Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28: 977-83.
6. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164: 396-402.
7. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004;39:206-17.
8. Marchetti O, Calandra T. Infection in the neutropenic cancer patient Infectious Diseases 2004, Second Edition; Chapter 100. Edited by Cohen J. and Povderly WG. Oxford: Elsevier Mosby, 2004;1077-92.
9. From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient Report of a consensus panel. J Infect Dis 1990; 161:397-401.
10. Hughes WT, Armstrong D, Bodey GP, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997;25:551-73.
11. Engel A, Steinbach G, Kern P, et al. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: Comparison with interleukin-8. Scand J Infect Dis 1999;31:185-9.
12. Fleischhack G, Kambeck I, Cipic D, et al. Procalcitonin in paediatric cancer patients: Its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000;111:1093-102.
13. Kallio R, Surcel HM, Bloigu A, et al. C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000;36:889-94.
14. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: Procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004;23:539-44.
15. Sauer M, Tiede K, Fuchs D, et al. Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: Identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant 2003;31:1137-42.
16. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P, et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: Experience from a multicentre study. Clin Microbiol Infect 2004;10:628-33.
17. de Bont ES, Vellenga E, Swaanenburg J, et al. Procalcitonin: A diagnostic marker of bacterial infection in neutropenic cancer patients with fever? Infection 2000; 28:398-400.
18. Ortega M, Rovira M, Filella X, et al. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br J Haematol 2004;126:372-6.
19. Robinson O, Calandra T, Bally F, et al. Utility of procalcitonin (PCT) as surrogate marker of bacterial infection in febrile neutropenic cancer patients. 44th ICAAC Washington 2004; Abstract D-1384.
20. Jimeno A, Garcia-Velasco A, del Val O, et al. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 2004;100:2462-9.
21. Schuttrumpf S, Binder L, Hagemann T, et al. Procalcitonin: A useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol 2003;82:98-103.
22. Ruokonen E, Nousiainen T, Pulkki K, et al. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 1999;18:283-5.
23. Preas HL, Nylen ES, Snider RH, et al. Effects of antiinflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis 2001;184:373-6.
24. Bernard L, Ferriere F, Casassus P, et al. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 1998;27:914-5.
25. Hambach L, Eder M, Dammann E, et al. Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 2002;87:643-51.
26. Persson L, Engervall P, Magnuson A, et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004;36:365-71.
27. Robinson O, Calandra T, Bally F, et al. A negative procalcitonin (PCT) test as an indicator of non-infectious fever (NIF) in neutropenic cancer patients with FUO. 14th ECCMID Prag 2004;Abstract O420.
28. Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, et al. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001;32:1718-25.
29. Christofilopoulou S, Charvalos E, Petrikkos G. Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med 2002;13:493-5.